Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amalia Colalillo

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Medicine|May 22, 2024
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patientsChiara Pellicano, Amalia Colalillo, Oriana De Marco, et al.
Microvascular Research|March 29, 2022
Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patientsChiara Pellicano, Laura Romaggioli, Marzia Miglionico, et al.
Journal of Personalized Medicine|September 28, 2023
In Systemic Sclerosis Patients, Peripheral Blood CD21<sup>low</sup> B Cells and Serum IL-4 and IL-21 Influence Joint InvolvementChiara Pellicano, Amalia Colalillo, Valeria Carnazzo, et al.
Clinical and Experimental Medicine|July 1, 2023
Type 2 cytokines and scleroderma interstitial lung diseaseChiara Pellicano, Lorenzo Vantaggio, Amalia Colalillo, et al.
Rheumatology (Oxford, England)|October 4, 2021
In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosisAmalia Colalillo, Maria Chiara Grimaldi, Valentina Vaiarello, et al.
Journal of Personalized Medicine|September 23, 2022
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis PatientsChiara Pellicano, Amalia Colalillo, Valerio Basile, et al.
Journal of Personalized Medicine|October 27, 2022
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic SclerosisGiorgia Leodori, Chiara Pellicano, Valerio Basile, et al.
Clinical and Experimental Rheumatology|March 28, 2025
Thymic stromal lymphopoietin in systemic sclerosis interstitial lung disease: a pilot studyChiara Pellicano, Giuseppina Cusano, Amalia Colalillo, et al.
Clinical Rheumatology|May 25, 2022
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosisChiara Pellicano, Roberta Campagna, Alessandra Oliva, et al.
Journal of Personalized Medicine|February 25, 2022
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung FibrosisChiara Pellicano, Marzia Miglionico, Laura Romaggioli, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Medicine|May 22, 2024
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patientsChiara Pellicano, Amalia Colalillo, Oriana De Marco, et al.
Microvascular Research|March 29, 2022
Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patientsChiara Pellicano, Laura Romaggioli, Marzia Miglionico, et al.
Journal of Personalized Medicine|September 28, 2023
In Systemic Sclerosis Patients, Peripheral Blood CD21<sup>low</sup> B Cells and Serum IL-4 and IL-21 Influence Joint InvolvementChiara Pellicano, Amalia Colalillo, Valeria Carnazzo, et al.
Clinical and Experimental Medicine|July 1, 2023
Type 2 cytokines and scleroderma interstitial lung diseaseChiara Pellicano, Lorenzo Vantaggio, Amalia Colalillo, et al.
Rheumatology (Oxford, England)|October 4, 2021
In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosisAmalia Colalillo, Maria Chiara Grimaldi, Valentina Vaiarello, et al.
Journal of Personalized Medicine|September 23, 2022
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis PatientsChiara Pellicano, Amalia Colalillo, Valerio Basile, et al.
Journal of Personalized Medicine|October 27, 2022
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic SclerosisGiorgia Leodori, Chiara Pellicano, Valerio Basile, et al.
Clinical and Experimental Rheumatology|March 28, 2025
Thymic stromal lymphopoietin in systemic sclerosis interstitial lung disease: a pilot studyChiara Pellicano, Giuseppina Cusano, Amalia Colalillo, et al.
Clinical Rheumatology|May 25, 2022
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosisChiara Pellicano, Roberta Campagna, Alessandra Oliva, et al.
Journal of Personalized Medicine|February 25, 2022
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung FibrosisChiara Pellicano, Marzia Miglionico, Laura Romaggioli, et al.
Pageof 3